In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.

[1]  T. Okano,et al.  Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[2]  M. Jones,et al.  Polymeric micelles - a new generation of colloidal drug carriers. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  C. J. Lee,et al.  Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Y. M. Lee,et al.  Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and DL-lactide block copolymer as novel drug carriers. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[5]  S Sardari,et al.  In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[6]  S. W. Kim,et al.  Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres. , 1998, Journal of biomedical materials research.

[7]  R. Panchagnula.  Pharmaceutical aspects of paclitaxel , 1998 .

[8]  Der,et al.  Enhanced oral absorption and decreased elimination of paclitaxel in mice cotreated with cyclosporin A. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  M. Wall,et al.  Camptothecin and taxol: Discovery to clinic , 1998, Medicinal research reviews.

[10]  Chun Xing Li,et al.  Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. , 1998, Cancer research.

[11]  K. E. Briggs,et al.  Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel. , 1998, International journal of oncology.

[12]  A S Hoffman,et al.  An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[13]  T. Okano,et al.  Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[14]  F. Dosio,et al.  Preparation, characterization and properties in vitro and in vivo of a paclitaxel–albumin conjugate , 1997 .

[15]  Sung Wan Kim,et al.  Biodegradable block copolymers as injectable drug-delivery systems , 1997, Nature.

[16]  A. Janoff,et al.  Activity of paclitaxel liposome formulations against human ovarian tumor xenografts , 1997, International journal of cancer.

[17]  J. Beijnen,et al.  Alternative formulations of paclitaxel. , 1997, Cancer treatment reviews.

[18]  B. Lundberg.  A Submicron Lipid Emulsion Coated with Amphipathic Polyethylene Glycol for Parenteral Administration of Paclitaxel (Taxol) , 1997, The Journal of pharmacy and pharmacology.

[19]  H. Sato,et al.  Pharmacokinetic study of taxol-loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate after targeted delivery to the lung in mice. , 1996, Biological & pharmaceutical bulletin.

[20]  H. Sato,et al.  Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol. , 1996, Chemical & pharmaceutical bulletin.

[21]  Teruo Okano,et al.  Polymeric micelles as new drug carriers , 1996 .

[22]  D. Thakker,et al.  Prodrugs of anticancer agents , 1996 .

[23]  H. Burt,et al.  Solubility and stability of taxol: effects of buffers and cyclodextrins , 1996 .

[24]  Stephen E. Harding,et al.  Polylactide−Poly(ethylene glycol) Copolymers as Drug Delivery Systems. 1. Characterization of Water Dispersible Micelle-Forming Systems , 1996 .

[25]  J. Beijnen,et al.  Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL. , 1996, Cancer research.

[26]  John K. Jackson,et al.  Development of amphiphilic diblock copolymers as micellar carriers of taxol , 1996 .

[27]  R B Greenwald,et al.  Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness. , 1996, Journal of medicinal chemistry.

[28]  J. Beijnen,et al.  Tissue distribution, metabolism and excretion of paclitaxel in mice , 1996, Anti-cancer drugs.

[29]  E. Cavallin-ståhl,et al.  A topographic study on the distribution of cisplatin in xenografted tumors on nude mice , 1996, Anti-cancer drugs.

[30]  R. Straubinger,et al.  Antitumor Efficacy of Taxane Liposomes on a Human Ovarian Tumor Xenograft in Nude Mice , 1995 .

[31]  S. Balasubramanian,et al.  Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. , 1995, Journal of pharmaceutical sciences.

[32]  R. Mertelsmann,et al.  Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. , 1995, Anti-cancer drugs.

[33]  M. Wani,et al.  Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture. , 1995, Cancer research.

[34]  W. Hunter,et al.  Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid). , 1995, Cancer letters.

[35]  D. Faulds,et al.  Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. , 1994, Drugs.

[36]  T. Cserháti,et al.  Interaction of taxol and other anticancer drugs with hydroxypropyl-β-cyclodextrin , 1994 .

[37]  T. Okano,et al.  Block copolymer micelles as vehicles for hydrophobic drugs , 1994 .

[38]  Barry R. Goldspiel.  Pharmaceutical Issues: Preparation, Administration, Stability, and Compatibility with other Medications , 1994, The Annals of pharmacotherapy.

[39]  K. Nicolaou,et al.  Chemistry and Biology of Taxol , 1994 .

[40]  R. Straubinger,et al.  Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. , 1993, Cancer research.

[41]  Gregory Re,et al.  Paclitaxel: a new antineoplastic agent for refractory ovarian cancer. , 1993 .

[42]  O. Fodstad,et al.  Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. , 1992, Cancer research.

[43]  S. Nightingale.  Wide Access Protocols for Breast Implants Approved , 1992 .

[44]  M. Boyd,et al.  Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen. , 1992, Anticancer research.

[45]  T. A. Hatton,et al.  Solubilization of polycyclic aromatic hydrocarbons by poly(ethylene oxide-propylene oxide) block copolymer micelles: effects of polymer structure , 1992 .

[46]  R. Donehower,et al.  Taxol: a novel investigational antimicrotubule agent. , 1990, Journal of the National Cancer Institute.

[47]  B. Leyland-Jones,et al.  Hypersensitivity reactions from taxol. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  K. Zhu,et al.  Preparation , Characterization , and Properties of Polylactide ( PLA )-Poly ( ethylene Glycol ) ( PEG ) Copolymers : A Potential Drug Carrier , 2017 .

[49]  P. Houghton,et al.  Role of murine tumor models in cancer treatment research. , 1986, Cancer research.

[50]  A. McPhail,et al.  Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.

[51]  E J Freireich,et al.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.

[52]  T. Okano,et al.  Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. , 1999, Journal of drug targeting.

[53]  G. Kwon,et al.  Diblock copolymer nanoparticles for drug delivery. , 1998, Critical reviews in therapeutic drug carrier systems.

[54]  Daniel Dexter,et al.  An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel , 1997, Cancer Chemotherapy and Pharmacology.

[55]  A. Maitra,et al.  Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy. , 1996, Oncology research.

[56]  G. Cavallaro,et al.  Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs. , 1996, Biomaterials.

[57]  Pişkin,et al.  Novel PDLLA/PEG copolymer micelles as drug carriers. , 1995, Journal of biomaterials science. Polymer edition.

[58]  J. Beijnen,et al.  Taxanes: a new class of antitumor agents. , 1995, Cancer investigation.

[59]  K. Kataoka.  Design of nanoscopic vehicles for drug targeting based on micellization of amphiphilic block copolymers , 1994 .

[60]  M. R. Mejillano,et al.  Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity. , 1992, Journal of medicinal chemistry.

[61]  D. V. Von Hoff,et al.  Analysis of anticancer drugs in biological fluids: determination of taxol with application to clinical pharmacokinetics. , 1990, Journal of pharmaceutical and biomedical analysis.

[62]  H. Fessi,et al.  In vitro and in vivo antitumoral activity of free, and encapsulated taxol. , 1990, Journal of microencapsulation.